SonoScape Medical Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Kunxiang Wu

İcra Kurulu Başkanı

CN¥900.0k

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	n/a
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	Veri yok

Son yönetim güncellemeleri

Recent updates

CEO

Kunxiang Wu (61 yo)

no data

Görev süresi

CN¥900,000

Tazminat

Mr. Kunxiang Wu is General Manager & Director of SonoScape Medical Corp.

SonoScape Medical Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

SonoScape Medical Corp., Annual General Meeting, May 10, 2024

SonoScape Medical Corp., Annual General Meeting, May 10, 2024

Less than half of directors are independent

SonoScape Medical Corp. Approves Board Elections

Insufficient new directors

SonoScape Medical Corp. Announces Executive Election

Recent updates

New minor risk - Profit margin trend

Now 23% overvalued

Investor sentiment deteriorates as stock falls 15%

SonoScape Medical Corp. to Report Q3, 2024 Results on Oct 26, 2024

Investor sentiment improves as stock rises 26%

Second quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.32 in 2Q 2023)

Now 21% overvalued

Investor sentiment deteriorates as stock falls 15%

SonoScape Medical Corp. to Report First Half, 2024 Results on Aug 29, 2024

Dividend increased to CN¥0.32

SonoScape Medical Corp. 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 29 May 2024

First quarter 2024 earnings released: EPS: CN¥0.23 (vs CN¥0.32 in 1Q 2023)

Full year 2023 earnings released: EPS: CN¥1.06 (vs CN¥0.86 in FY 2022)

SonoScape Medical Corp., Annual General Meeting, May 10, 2024

SonoScape Medical Corp., Annual General Meeting, May 10, 2024

SonoScape Medical Corp. to Report Q1, 2024 Results on Apr 27, 2024

Less than half of directors are independent

Investor sentiment improves as stock rises 17%

SonoScape Medical Corp. Approves Board Elections

SonoScape Medical Corp. to Report Fiscal Year 2023 Results on Apr 12, 2024

Now 21% undervalued

SonoScape Medical Corp. (SZSE:300633) announces an Equity Buyback for CNY 120 million worth of its shares.

SonoScape Medical Corp. (SZSE:300633) announces an Equity Buyback for CNY 120 million worth of its shares.

Third quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.17 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.32 (vs CN¥0.29 in 2Q 2022)

SonoScape Medical Corp. to Report Q2, 2023 Results on Aug 23, 2023

SonoScape Medical Corp. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 June 2023

Full year 2022 earnings released: EPS: CN¥0.86 (vs CN¥0.62 in FY 2021)

Investor sentiment improved over the past week

Insufficient new directors

Third quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.076 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.29 (vs CN¥0.18 in 2Q 2021)

Investor sentiment improved over the past week

Sonoscape Medical Corp. Announces Final Dividend on Share A for 2021, Payable on July 15, 2022

SonoScape Medical Corp. Approves 2021 Profit Distribution Plan

SonoScape Medical Corp. Proposes Final Cash Dividend for 2021

First quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.09 in 1Q 2021)

SonoScape S-Fetus 4.0 Release to Simplify Sonography Process

SonoScape Medical Corp. Receives FDA 510(k) Clearance for HD-550 Endoscopy system

Third quarter 2021 earnings released: EPS CN¥0.076 (vs CN¥0.004 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.085 in 2Q 2020)

SonoScape Obtains CE-Mark for Its Linear Array Echoendoscope EG-UC5T

Sonoscape Medical Corp. Proposes Final Cash Dividend for 2020

First quarter 2021 earnings released: EPS CN¥0.09 (vs CN¥0.02 loss in 1Q 2020)

New 90-day low: CN¥20.36

SonoScape Medical Corp. Announces Executive Election

New 90-day low: CN¥21.50

New 90-day low: CN¥24.31

Third quarter earnings released

SonoScape Medical Corp. announced that it expects to receive CNY 1.2 billion in funding

New 90-day low: CN¥27.25

Earnings released

New 90-day low - CN¥30.72

SonoScape Medical Corp. to Report First Half, 2020 Results on Aug 26, 2020

CEO

Görev süresi

Tazminat